{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:29:35Z","timestamp":1788294575525,"version":"build-2803163510"},"reference-count":53,"publisher":"American Association for Cancer Research (AACR)","issue":"6","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA229092"],"award-info":[{"award-number":["P01CA229092"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA206978"],"award-info":[{"award-number":["P01CA206978"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["SCOR-22937-22"],"award-info":[{"award-number":["SCOR-22937-22"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2023_EKEA.102"],"award-info":[{"award-number":["2023_EKEA.102"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020046","name":"DKMS Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA245209"],"award-info":[{"award-number":["K08CA245209"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Combined tracking of clonal evolution and chimeric cell phenotypes could enable detection of the key cellular populations associated with response following therapy, including after allogeneic hematopoietic stem cell transplantation (HSCT). We demonstrate that mitochondrial DNA (mtDNA) mutations coevolve with somatic nuclear DNA mutations at relapse post-HSCT and provide a sensitive means to monitor these cellular populations. Furthermore, detection of mtDNA mutations via single-cell assay for transposase-accessible chromatin with select antigen profiling by sequencing (ASAP-seq) simultaneously determines not only donor and recipient cells but also their phenotype at frequencies of 0.1% to 1%. Finally, integration of mtDNA mutations, surface markers, and chromatin accessibility profiles enables the phenotypic resolution of leukemic populations from normal immune cells, thereby providing fresh insights into residual donor-derived engraftment and short-term clonal evolution following therapy for post-transplant leukemia relapse. As throughput evolves, we envision future development of single-cell sequencing\u2013based post-transplant monitoring as a powerful approach for guiding clinical decision-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>mtDNA mutations enable single-cell tracking of leukemic clonal evolution and donor\u2013recipient origin following allogeneic HSCT. This provides unprecedented insight into chimeric cellular phenotypes of early immune reconstitution, incipient relapse, and quality of donor engraftment with immediate translational potential for future clinical post-transplant monitoring and decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-23-0138","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T16:04:52Z","timestamp":1725552292000},"page":"442-459","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tracking Rare Single Donor and Recipient Immune and Leukemia Cells after Allogeneic Hematopoietic Cell Transplantation Using Mitochondrial DNA Mutations"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9060-0207","authenticated-orcid":false,"given":"Livius","family":"Penter","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."},{"name":"4Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Charit\u00e9 - Universita\u0308tsmedizin Berlin, Corporate Member of Freie Universita\u0308t Berlin and Humboldt-Universita\u0308t zu Berlin, Berlin, Germany."},{"name":"5Berlin Institute of Health at Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charit\u00e9 Digital Clinician Scientist Program, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-6272","authenticated-orcid":false,"given":"Nicoletta","family":"Cieri","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-181X","authenticated-orcid":false,"given":"Katie","family":"Maurer","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3985-5079","authenticated-orcid":false,"given":"Marwan","family":"Kwok","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."},{"name":"6Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0165-9934","authenticated-orcid":false,"given":"Haoxiang","family":"Lyu","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"7Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5584-041X","authenticated-orcid":false,"given":"Wesley S.","family":"Lu","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"7Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7435-5603","authenticated-orcid":false,"given":"Giacomo","family":"Oliveira","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-991X","authenticated-orcid":false,"given":"Satyen H.","family":"Gohil","sequence":"additional","affiliation":[{"name":"8Department of Haematology, University College London Hospitals, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8942-9265","authenticated-orcid":false,"given":"Ignaty","family":"Leshchiner","sequence":"additional","affiliation":[{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-4807","authenticated-orcid":false,"given":"Caleb A.","family":"Lareau","sequence":"additional","affiliation":[{"name":"9Memorial Sloan Kettering Cancer Center, New York City, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-2164","authenticated-orcid":false,"given":"Leif S.","family":"Ludwig","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Charit\u00e9 - Universita\u0308tsmedizin Berlin, Corporate Member of Freie Universita\u0308t Berlin and Humboldt-Universita\u0308t zu Berlin, Berlin, Germany."},{"name":"10Berlin Institute of Health at Charit\u00e9 Universit\u00e4tsmedizin Berlin, Berlin, Germany."},{"name":"11Max-Delbr\u00fcck-Center for Molecular Medicine in the Helmholtz Association, Berlin Institute for Medical Systems Biology, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-3145","authenticated-orcid":false,"given":"Donna S.","family":"Neuberg","sequence":"additional","affiliation":[{"name":"12Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4889-6849","authenticated-orcid":false,"given":"Haesook T.","family":"Kim","sequence":"additional","affiliation":[{"name":"12Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-6141","authenticated-orcid":false,"given":"Shuqiang","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"7Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5890-5510","authenticated-orcid":false,"given":"Lars","family":"Bullinger","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Oncology, and Tumorimmunology, Campus Virchow Klinikum, Charit\u00e9 - Universita\u0308tsmedizin Berlin, Corporate Member of Freie Universita\u0308t Berlin and Humboldt-Universita\u0308t zu Berlin, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-4669","authenticated-orcid":false,"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-6302","authenticated-orcid":false,"given":"Jacqueline S.","family":"Garcia","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5810-1192","authenticated-orcid":false,"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-5856","authenticated-orcid":false,"given":"Kenneth J.","family":"Livak","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"7Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3348-5054","authenticated-orcid":false,"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."},{"name":"2Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts."},{"name":"3Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"2026041310193325000_bib1","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1158\/0008-5472.CAN-21-0301","article-title":"60 years young: the evolving role of allogeneic hematopoietic stem cell transplantation in cancer immunotherapy","volume":"81","author":"Cieri","year":"2021","journal-title":"Cancer Res"},{"key":"2026041310193325000_bib2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1172\/JCI129209","article-title":"Personal tumor antigens in blood malignancies: genomics-directed identification and targeting","volume":"130","author":"Penter","year":"2020","journal-title":"J Clin Invest"},{"key":"2026041310193325000_bib3","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1158\/1078-0432.CCR-22-0809","article-title":"Longitudinal outcome over two decades of unrelated allogeneic stem cell transplantation for relapsed\/refractory acute myeloid leukemia: an ALWP\/EBMT analysis","volume":"28","author":"Nagler","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2026041310193325000_bib4","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/bloodadvances.2020001956","article-title":"Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents","volume":"4","author":"Roeker","year":"2020","journal-title":"Blood Adv"},{"key":"2026041310193325000_bib5","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3324\/haematol.2015.129650","article-title":"Efficacy of immune suppression tapering in treating relapse after reduced intensity allogeneic stem cell transplantation","volume":"100","author":"Kekre","year":"2015","journal-title":"Haematologica"},{"key":"2026041310193325000_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/bloodadvances.2018016121","article-title":"Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort","volume":"2","author":"Stahl","year":"2018","journal-title":"Blood Adv"},{"key":"2026041310193325000_bib7","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.bbmt.2014.07.010","article-title":"Donor lymphocyte infusion for the treatment of relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation","volume":"20","author":"Takami","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"2026041310193325000_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/2159-8290.CD-18-0774","article-title":"Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed\/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study","volume":"9","author":"Daver","year":"2019","journal-title":"Cancer Discov"},{"key":"2026041310193325000_bib9","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/bloodadvances.2021004335","article-title":"Coevolving JAK2V617F+ relapsed AML and donor T cells with PD-1 blockade after stem cell transplantation: an index case","volume":"5","author":"Penter","year":"2021","journal-title":"Blood Adv"},{"key":"2026041310193325000_bib10","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood.2022017686","article-title":"Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-na\u00efve settings","volume":"141","author":"Garcia","year":"2023","journal-title":"Blood"},{"key":"2026041310193325000_bib11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41409-023-01985-7","article-title":"Second haploidentical stem cell transplantation (HAPLO-SCT2) after relapse from a first HAPLO-SCT in acute leukaemia\u2014a study on behalf of the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)","volume":"58","author":"Filippini Vel\u00e1zquez","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"2026041310193325000_bib12","doi-asserted-by":"crossref","first-page":"788891","DOI":"10.3389\/fimmu.2021.788891","article-title":"Natural barcodes for longitudinal single cell tracking of leukemic and immune cell dynamics","volume":"12","author":"Penter","year":"2022","journal-title":"Front Immunol"},{"key":"2026041310193325000_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12862-018-1198-x","article-title":"Mind the gap! The mitochondrial control region and its power as a phylogenetic marker in echinoids","volume":"18","author":"Bronstein","year":"2018","journal-title":"BMC Evol Biol"},{"key":"2026041310193325000_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41587-020-0645-6","article-title":"Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling","volume":"39","author":"Lareau","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2026041310193325000_bib15","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1158\/2159-8290.CD-21-0276","article-title":"Longitudinal single-cell dynamics of chromatin accessibility and mitochondrial mutations in chronic lymphocytic leukemia mirror disease history","volume":"11","author":"Penter","year":"2021","journal-title":"Cancer Discov"},{"key":"2026041310193325000_bib16","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.stem.2023.04.001","article-title":"Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia","volume":"30","author":"Beneyto-Calabuig","year":"2023","journal-title":"Cell Stem Cell"},{"key":"2026041310193325000_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1158\/0008-5472.CAN-22-0275","article-title":"Mitochondrial DNA mutations as natural barcodes for lineage tracing of murine tumor models","volume":"83","author":"Penter","year":"2023","journal-title":"Cancer Res"},{"key":"2026041310193325000_bib18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-019-1252-x","article-title":"Growth dynamics in naturally progressing chronic lymphocytic leukaemia","volume":"570","author":"Gruber","year":"2019","journal-title":"Nature"},{"key":"2026041310193325000_bib19","doi-asserted-by":"crossref","first-page":"eabb7661","DOI":"10.1126\/scitranslmed.abb7661","article-title":"Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to the graft-versus-leukemia effect","volume":"12","author":"Bachireddy","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026041310193325000_bib20","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1182\/blood-2011-09-381699","article-title":"Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia","volume":"119","author":"Saber","year":"2012","journal-title":"Blood"},{"key":"2026041310193325000_bib21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41409-023-01980-y","article-title":"Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP\/EBMT","volume":"58","author":"Nagler","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"2026041310193325000_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/13779","article-title":"Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA","volume":"23","author":"Andrews","year":"1999","journal-title":"Nat Genet"},{"key":"2026041310193325000_bib23","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat Commun"},{"key":"2026041310193325000_bib24","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1093\/nar\/gkz164","article-title":"Splice-break: exploiting an RNA-seq splice junction algorithm to discover mitochondrial DNA deletion breakpoints and analyses of psychiatric disorders","volume":"47","author":"Hjelm","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026041310193325000_bib25","doi-asserted-by":"crossref","first-page":"e77943","DOI":"10.7554\/eLife.77943","article-title":"Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study","volume":"11","author":"Hu","year":"2022","journal-title":"Elife"},{"key":"2026041310193325000_bib26","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41587-022-01210-8","article-title":"Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populations","volume":"40","author":"Miller","year":"2022","journal-title":"Nat Biotechnol"},{"key":"2026041310193325000_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41467-023-44137-7","article-title":"Integrative genotyping of cancer and immune phenotypes by long-read sequencing","volume":"15","author":"Penter","year":"2024","journal-title":"Nat Commun"},{"key":"2026041310193325000_bib28","doi-asserted-by":"crossref","first-page":"1.23","DOI":"10.1002\/0471250953.bi0123s44","article-title":"mtDNA variation and analysis using mitomap and mitomaster","volume":"44","author":"Lott","year":"2013","journal-title":"Curr Protoc Bioinformatics"},{"key":"2026041310193325000_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41592-020-0820-1","article-title":"Souporcell: robust clustering of single-cell RNA-seq data by genotype without reference genotypes","volume":"17","author":"Heaton","year":"2020","journal-title":"Nat Methods"},{"key":"2026041310193325000_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13059-019-1865-2","article-title":"Vireo: bayesian demultiplexing of pooled single-cell RNA-seq data without genotype reference","volume":"20","author":"Huang","year":"2019","journal-title":"Genome Biol"},{"key":"2026041310193325000_bib31","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.2022018246","article-title":"Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease","volume":"141","author":"Penter","year":"2023","journal-title":"Blood"},{"key":"2026041310193325000_bib32","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41587-021-00927-2","article-title":"Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells","volume":"39","author":"Mimitou","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2026041310193325000_bib33","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"2026041310193325000_bib34","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-022-01819-x","article-title":"A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia","volume":"28","author":"Zeng","year":"2022","journal-title":"Nat Med"},{"key":"2026041310193325000_bib35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.blre.2017.05.001","article-title":"Interleukin-1\u03b2 as emerging therapeutic target in hematological malignancies and potentially in their complications","volume":"31","author":"Arranz","year":"2017","journal-title":"Blood Rev"},{"key":"2026041310193325000_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2016.00507","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Ogonek","year":"2016","journal-title":"Front Immunol"},{"key":"2026041310193325000_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJMoa1601202","article-title":"Ipilimumab for patients with relapse after allogeneic transplantation","volume":"375","author":"Davids","year":"2016","journal-title":"N Engl J Med"},{"key":"2026041310193325000_bib38","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood.2021010867","article-title":"Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation","volume":"137","author":"Penter","year":"2021","journal-title":"Blood"},{"key":"2026041310193325000_bib39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jmoldx.2016.02.003","article-title":"Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies","volume":"18","author":"Kluk","year":"2016","journal-title":"J Mol Diagn"},{"key":"2026041310193325000_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12943-022-01548-2","article-title":"Clinical significance of FBXW7 loss of function in human cancers","volume":"21","author":"Fan","year":"2022","journal-title":"Mol Cancer"},{"key":"2026041310193325000_bib41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/s41586-024-07388-y","article-title":"Mapping genotypes to chromatin accessibility profiles in single cells","volume":"629","author":"Izzo","year":"2024","journal-title":"Nature"},{"key":"2026041310193325000_bib42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.46989\/001c.117961","article-title":"Single-cell genomics-based immune and disease monitoring in blood malignancies","volume":"6","author":"Rathgeber","year":"2024","journal-title":"Clin Hematol Int"},{"key":"2026041310193325000_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat Methods"},{"key":"2026041310193325000_bib44","doi-asserted-by":"crossref","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"2026041310193325000_bib45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2026041310193325000_bib46","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1093\/bioinformatics\/btab358","article-title":"Cellsnp-lite: an efficient tool for genotyping single cells","volume":"37","author":"Huang","year":"2021","journal-title":"Bioinformatics"},{"key":"2026041310193325000_bib47","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41596-022-00795-3","article-title":"Mitochondrial single-cell ATAC-seq for high-throughput multi-omic detection of mitochondrial genotypes and chromatin accessibility","volume":"18","author":"Lareau","year":"2023","journal-title":"Nat Protoc"},{"key":"2026041310193325000_bib48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41586-021-03704-y","article-title":"Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma","volume":"596","author":"Oliveira","year":"2021","journal-title":"Nature"},{"key":"2026041310193325000_bib49","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41588-021-00790-6","article-title":"ArchR is a scalable software package for integrative single-cell chromatin accessibility analysis","volume":"53","author":"Granja","year":"2021","journal-title":"Nat Genet"},{"key":"2026041310193325000_bib50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41587-021-00870-2","article-title":"Modular, efficient and constant-memory single-cell RNA-seq preprocessing","volume":"39","author":"Melsted","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2026041310193325000_bib51","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2026041310193325000_bib52","doi-asserted-by":"crossref","first-page":"6566","DOI":"10.1038\/s41467-021-26865-w","article-title":"Fast alignment and preprocessing of chromatin profiles with Chromap","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"2026041310193325000_bib53","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-23-0138\/3494082\/bcd-23-0138.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-23-0138\/3507719\/bcd-23-0138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/5\/6\/442\/3509535\/bcd-23-0138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/5\/6\/442\/3509535\/bcd-23-0138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:19:50Z","timestamp":1776089990000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/5\/6\/442\/749230\/Tracking-Rare-Single-Donor-and-Recipient-Immune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,9,5]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-23-0138","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.c.7520326","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.27434137","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434119","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434053","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434110","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434152","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434065","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434140","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434146","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434089","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434122","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434134","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434047","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434071","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434095","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434083","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434104","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434116","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434143","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434086","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434131","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434074","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434044","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434113","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434056","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434125","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434101","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434155","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434080","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434161","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434092","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.27434062","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}